Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
In a world constantly in motion, Microbioz India r
The World Health Organization (WHO) issued fresh clinical advice on Tuesday for treating COVID-19 patients, including those displaying persistent symptoms after recovery, and said it suggested using low-dose coagulants to prevent blood clots.
WHO spokeswoman Margaret Harris told a UN briefing in Geneva that a WHO-led group of independent experts, currently in the central Chinese city of Wuhan in which the first human cases were detected in December 2019, is due to leave quarantine in the next two days to pursue its work on the virus origins.
Harris declined to commment on reports of delays in roll-out of vaccines in the European Union. She said she had no specific information along with the WHO’s priority was to get health workers in all states to be vaccinated in the first 100 days of the year.